Invention Grant
- Patent Title: GCN2 inhibitors and uses thereof
-
Application No.: US16907622Application Date: 2020-06-22
-
Publication No.: US12084438B2Publication Date: 2024-09-10
- Inventor: Matthew Bleich , Jean-Damien Charrier , Huijun Dong , Steven Durrant , Meredith Suzanne Eno , Gorka Etxebarria I Jardi , Simon Everitt , Damien Fraysse , Ronald Knegtel , Igor Mochalkin , Kiri North , Filippos Porichis , Hui Qiu , Robert Pullin , Pierre-Henri Storck , Heather Clare Twin , Yufang Xiao
- Applicant: Merck Patent GmbH , Vertex Pharmaceuticals Incorporated
- Applicant Address: DE MA Darmstadt
- Assignee: Merck Patent GmbH,Vertex Pharmaceuticals Incorporated
- Current Assignee: Merck Patent GmbH,Vertex Pharmaceuticals Incorporated
- Current Assignee Address: DE Darmstadt; US MA Boston
- Agency: Dechert LLP
- Agent Andrea L. C. Reid; Gang Wang
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; A61P35/00
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same.
Public/Granted literature
- US20210040083A1 GCN2 INHIBITORS AND USES THEREOF Public/Granted day:2021-02-11
Information query
